Titre :
  • Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: A landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
Auteur : Bonnefoi, Herve ; Litière, Saskia ; Piccart-Gebhart, Martine ; MacGrogan, Gaetan ; Fumoleau, Pierre P. ; Brain, Etienne ; Petit, Thierry ; Rouanet, Philippe ; Jassem, Jacek ; Moldovan, Cristian C. ; Bodmer, Alexandre A. ; Zaman, Khalil ; Cufer, Tanja ; Campone, Mario ; Luporsi, Élisabeth E. ; Malmström, Per Olof P. ; Werutsky, Gustavo ; Bogaerts, Jan ; Bergh, Jonas ; Cameron, David A
Informations sur la publication : Annals of oncology, 25, 6, (page 1128-1136)
Statut de publication : Publié, 2014
Sujet CREF : Hématologie
Cancérologie
Mots-clés : Breast cancer
Landmark analysis
Neoadjuvant chemotherapy
Pathological complete response
TP53
Mots-clés MeSH : Adult
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- mortality
Carcinoma, Ductal, Breast -- drug therapy -- metabolism -- mortality
Chemotherapy, Adjuvant -- mortality
Disease-Free Survival
Female
Humans
Middle Aged
Neoadjuvant Therapy -- mortality
Prognosis
Proportional Hazards Models
Treatment Outcome
Tumor Suppressor Protein p53 -- biosynthesis
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdu118
info:pii/mdu118
info:pmid/24618153